Table 2.

Clinical characteristics and anatomical outcomes at diagnosis and at one year for eyes diagnosed with sequential neovascular age-related macular degeneration

Characteristic	Groups
	First Eye	Second Eye	P-value 1
VA, logMAR (SD)
At diagnosis	0.68 (0.51)	0.41 (0.34)	0.002 2
At 12 months	0.61 (0.60)	0.42 (0.37)	0.041 2
P-value1	0.241 2	0.872 2
CMT, µm (SD)
At diagnosis	340 (92)	311 (73)	0.0792
At 12 months	272 (57)	265 (53)	0.4672
P-value1	< 0.0012	< 0.0012
Hemorrhage, n (%)
At diagnosis	10 (19.2)	6 (11.5)	0.4163
At 12 months	1 (1.9)	3 (5.8)	0.6183
P-value1	0.008 3	0.488 3
IRF, n (%)
At diagnosis	31 (59.6)	37 (71.2)	0.2164
At 12 months	26 (50.0)	27 (51.9)	0.8454
P-value1	0.325 4	0.044 4
SRF, n (%)
At diagnosis	42 (80.8)	16 (30.8)	<0.001 4
At 12 months	17 (32.7)	17 (32.7)	1.00 4
P-value1	< 0.0014	0.833 4
PED, n (%)
At diagnosis	47 (90.4)	46 (88.5)	0.750 4
At 12 months	44 (84.6)	44 (84.6)	1.004
P-value1	0.374 4	0.5664
PED, µm (SD)
At diagnosis	225 (176)	155 (144)	0.003 5
At 12 months	188 (137)	140 (112)	0.0194
P-value1	0.322 5	0.9285

¹Significance is marked in bold (P < 0.05). ²Student’s t-test. ³Fisher exact test. ⁴Chi–square test. ⁵Mann–Whitney U test